Everyone Is Talking About Monoclonal Antibodies as Treatment For Reducing Risk of Symptomatic COVID — Is It an Option for Those With Cancer?

Published Jan 26, 2021

Everyone Is Talking About Monoclonal Antibodies as Treatment For Reducing Risk of Symptomatic COVID — Is It an Option for Those With Cancer?

There is a lot of talk around monoclonal antibodies and how they might be able to help those with COVID-19. While there is much to understand around how it works and if it's right for those fighting cancer, the outlook is positive.

NOW
PLAYING
Facebook Executive and Blood Cancer Warrior Nicola Mendelsohn Talks about Struggles of Staying Safe from COVID-19
NOW
PLAYING
Delayed Cancer Screenings Due to COVID: What to Do Now
NOW
PLAYING
Woman Who Beat Cancer 10 Years Ago & Fostered 62 Children Passes from COVID-19
NOW
PLAYING
Cancer Patients Should Still Wear Masks & Distance Says Leading Expert - Even in Wake of Major New CDC Guidelines
NOW
PLAYING
A Significant Number of Cancer Patients are Lonely, New Research Suggests
NOW
PLAYING
Recent Study Reveals Nearly 10 Million Cancer Screenings Were Skipped During COVID-19; Don't Miss These Life-Saving Resources

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.